Fox Chase Cancer Center
Latest from Fox Chase Cancer Center
Shifts in Oncology: Safely Treating Patients in a Post–COVID-19 World
February 09, 2022
Article
The COVID-19 pandemic has affected oncology practice in many ways. What will safe treating look like moving forward?
Axitinib/Pembrolizumab Combination Improves Survival in Metastatic RCC, But Only Marginally
October 17, 2021
Article
A real-world survival analysis showed that patients with metastatic RCC treated with axitinib plus pembrolizumab did not experience significantly improved survival outcomes compared with patients treated with ipilimumab plus nivolumab.